References
- Lightdale C. Esophageal cancer. American college of gastroenterology. Am. J. Gastroent. 1999; 94(1)20–29, [PUBMED], [INFOTRIEVE]
- Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res. 2000; 155: 1–11, [PUBMED], [INFOTRIEVE], [CSA]
- De Vita V., Hellman S., Rosenberg S. Cancer: Principals and Practice of Oncology6th Ed. Lippincott Williams and Wilkins, Philadelphia, PA 2001
- Bollschweiler E., Wolfgarten E., Nowroth T., Rosendahl U., Monig S. P., Holscher A. H. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J. Cancer Res. Clin. Oncol. 2002; 128(10)575–580, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jaskiewicz K., Marasas W., Lazarus C., Beyers A. D., Van Helden P. D. Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res. 1988; 8(4)711–715, [PUBMED], [INFOTRIEVE], [CSA]
- Heath E. I., Limburg P. J., Hawk E. T., Forastiere A. A. Adenocarcinoma of the esophagus: risk factors and prevention. Oncology (Huntingt) 2000; 14(4)507–514, (discussion 518–20, 522–3)[CSA]
- Pera M., Cameron A., Trastek V. F., Carpenter H. A., Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104(2)510–513, [PUBMED], [INFOTRIEVE]
- Bytzer P., Christensen P., Damkier P., Vinding K., Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am. J. Gastroenterol. 1999; 94(1)86–91, [PUBMED], [INFOTRIEVE]
- Holscher A. H., Bollschweiler E., Schneider P. M., Siewert J. R. Early adenocarcinoma in Barretts oesophagus. Br. J. Surg. 1997; 84(10)1470–1473, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Clark G., Smyrk T. C., Burdiles P., Hoeft S. F., Peters J. H., Kiyabu M., Hinder R. A., Bremner C. G., DeMeester T. R. Is barrett's metaplasia the source of adenocarcinomas of the cardia?. Arch. Surg. 1994; 129(6)609–614, [PUBMED], [INFOTRIEVE], [CSA]
- Chow W., Finkle W., McLaughin J., Frankl H., Ziel H. K., Fraumeni J. F., Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. JAMA 1995; 274(6)474–477, [PUBMED], [INFOTRIEVE], [CROSSREF]
- DeMeester T. Esophageal carcinoma: current controversies. Sem. Surg. Oncol. 1997; 13: 217–233, [CROSSREF], [CSA]
- Fein M., Fuchs K., Ritter M., Freys S. M., Heimbucher, Staab C., Thiede A. Application of the new classification for cancer of the cardia. Surgery 1998; 124(4)707–713, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Siewert J., Stein H. Classification of adenocarcinoma of the oesophagogastric junction. Br. J. Surg. 1998; 85(11)1457–1459, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Farrow D., Vaughan T. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996; 7: 322–327, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reed C. Surgical management of esophageal carcinoma. Oncologist 1999; 4: 95–105, [PUBMED], [INFOTRIEVE], [CSA]
- Fleming I., Cooper J., Henson D. AJCC Cancer Staging Manual5th Ed. Lippincott-Raven, Philadelphia, PA 1997
- Steup W., De Leyn P., Deneffe G., Van Raemdonck D., Coosemans W., Lerut T. Tumors of the esophagogastricjunction. Long-term survival in relation to the pattern of lymph node metastasis and critical analysis of the accuracy and inaccuracy of pTNM classification. J. Thorac. Cardiovasc. Surg. 1996; 111(1)85–95, [PUBMED], [INFOTRIEVE]
- Korst R., Rusch V., Venkatraman E., Bains M. S., Burt M. E., Downey R. J., Ginsberg R. J. Proposed revision of the staging classification for esophageal carcinoma. J. Thorac. Cardiovasc. Surg. 1998; 115(3)660–670, [PUBMED], [INFOTRIEVE]
- Botet J., Lightdale C., Zauber A., Gerdes H., Urmacher C., Brennan M. F. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 1991; 181(2)419–425, [PUBMED], [INFOTRIEVE]
- Vickers J., Anderson D. Oesophageal cancer staging using endoscopic ultrasonography. Br. J. Surg. 1998; 85: 994–998, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Massari M., Cioffi U., De Simone M., Lattuada E., Montorsi M., Segalin A., Bonavina L. Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. Surg. Laparosc. Endosc. 1997; 7(2)162–165, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Laterza E., de Manzoni G., Guglielmi A., Rodella L., Tedesco P., Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann. Thorac. Surg. 1999; 67(5)1466–1469, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Meltzer C., Luketich J., Friedman D., Charron M., Strollo D., Meehan M., Urso G. K., Dachille M. A., Townsend D. W. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin. Nucl. Med. 2000; 25(11)882–887, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lerut T., Flarnen P., Ectors N., Van Cutsem E., Peeters M., Hiele M., De Wever W., Coosemans W., Decker G., De Leyn P., Deneffe G., Van Raemdonck D., Mortelmans L. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction. Ann. Surg. 2000; 232(6)743–752, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kransa M., Jiao X. Use of minimally invasive surgery in staging esophageal cancer. J. Laparoendosc. Adv. Surg. Tech. Part A 2000; 10: 161–164, [CSA]
- Krasna M., Reed C., Nedzwiecki D., Hollis D., Luketich J., DeCamp M., Mayer R., Sugarbaker D. CALGB 9380: A Prospective Trial of the Feasibility of Thoracoscopy/Laparoscopy in Staging Esophageal Cancer
- Akiyama H., Tsurumaru M., Kawamura T., Ono Y. Principals of surgical treatment for carcinomas of the esophagus: Analysis of lymph node involvement. Ann. Surg. 1981; 194(4)438–446, [PUBMED], [INFOTRIEVE]
- Dresner S., Lamb P., Bennett M., Hayes N., Griffin S. M. The pattern of lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001; 129(1)103–109, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- O'Sullivan G., Shanahan F. Esophagogastric cancer-time to change the pardigm. Am. J. Gastroenterol. 2000; 95: 2153–2154, [PUBMED], [INFOTRIEVE]
- Bonavina L., Soligo D., Quirici N., Bossolasco P., Cesana B., Lembertenghi Deliliers G., Peracchia A. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery 2001; 129(1)15–22, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- O'Sullivan G., Sheehan D., Clarke A., Stuart R., Kelly J., Kiely M. D., Walsh T., Collins J. K., Shanahan F. Micrometastase in esophagogastric cancer: High detection rate in resected rib segments. Gastroenterology 1999; 116(3)543–548, [PUBMED], [INFOTRIEVE], [CSA]
- Thorban S., Rosenberg R., Busch R., Roder R. J. Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br. J. Cancer 2000; 83(1)35–39, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mansi J., Berger U., Easton D., McDonnell T., Redding W. H., Gazet J. C., McKinna A., Powles T. J., Coombes R. C. Micrometastasis in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastasis. Br. Med. J. 1987; 295(6606)1093–1096
- Cote R., Rosen P., Lesser M., Old L. J., Osborne M. P. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastasis. J. Clin. Oncol. 1991; 9(10)1749–1756, [PUBMED], [INFOTRIEVE]
- Cote R., Beattie E., Chaiwun B., Shi S. R., Harvey J., Chen S. C., Sherrod A. E., Groshen S., Taylor C. R. Detection of occult bone marrow micrometastasis in patients with operable lung cancer. Ann. Surg. 1995; 222(4)415–425, [PUBMED], [INFOTRIEVE]
- Lindemann F., Schlimok G., Drischedl P., Witte J., Riethmuller G. Prognostic significance of micro metastatic tumor cells in bone marrow of colorectal cancer patients. Lancet 1992; 340(8821)685–689, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Braun S., Pantel K. Micrometastatic bone marrow involvement: detection and prognostic significance. Med. Oncol. 1999; 16: 154–165, [PUBMED], [INFOTRIEVE]
- Ellis F., Heatley G., Krasna M., Heatley G. J., Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J. Cardiovasc. Surg. 1997; 113(5)836–848
- Sandick J., van Lanschot J., ten Kate F., Offerhaus G. J., Fockens P., Tytgat G. N., Obertop H. Pathology of early invasive adenocarcinoma of the esophagus or esophagogastricjunction. Cancer 2000; 88(11)2429–2437, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nijhawan P., Wang K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastroenterol. Endosc. 2000; 52: 328–332, [CROSSREF]
- Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., Henrich R., Vieth M., Muller H., Seitz G., Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118(4)670–677, [PUBMED], [INFOTRIEVE], [CSA]
- Noguchi H., Naomoto Y., Kondo H., Haisa M., Yamatsuji T., Shigemitsu K., Aoki H., Isozaki H., Tanaka N. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg. Laporosc. Percutan. Tech. 2000; 10(6)343–350, [CROSSREF], [CSA]
- Fujita H., Sueyoshi S., Yamana H. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J. Surg. 2001; 25: 424–431, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stein H., Feith M., Mueller J., Werner M., Siewert J. R. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann. Surg. 2000; 232(6)733–742, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Luketich J., Schauer P., Urso K., Kassis E., Ferson P., Keenan R., Landreneau R. Future direction in esophageal cancer. Chest 1998; 113(1 Suppl)120–122
- Swanstrom L., Hanses P. Laparoscopic total esophagectomy. Arch. Surg. 1997; 132: 943–949, [PUBMED], [INFOTRIEVE], [CSA]
- Nguyen N., Luketich J. Minimal access approach to esophagectomy. Minimal Access Cardiothoracic Surgery, A. Yim. WB Saunders, Orlando 1999; 277–280
- Luketich J., Schauer P., Christie N., Weigel T. L., Raja S., Fernando H. C., Keenan R. J., Nguyen N. T. Minimally invasive esophagectomy. Ann. Thorac. Surg. 2000; 70(3)906–912, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fernando H., Christie N., Luketich J. Thoracoscopic and laparoscopic esophagectomy. Semin. Thorac. Cardiovasc. Surg. 2000; 12: 195–200, [PUBMED], [INFOTRIEVE]
- Law S., Fok M., Chu K., Wong J. Thoracoscopic esophagectomy for esophageal cancer. Surgery 1997; 122(1)8–14, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Daly J., Fry W., Little A., Winchester D. P., McKee R. F., Stewart A. K., Fremgen A. M. Esophageal cancer: results of an American college of surgeon patient care evaluation study. J. Am. Coll. Surg. 2000; 190(5)562–573, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Muller J., Erasmi H., Stelzner M., Zieren U., Pichlmaier H. Surgical therapy of oesophageal cancer. Br. J. Surg. 1990; 77(8)845–857, [PUBMED], [INFOTRIEVE]
- Newaishy G., Read G., Duncan W., Kerr G. R. Results of radical radiotherapy of squamous cell carcinoma of the esophagus. Clin. Radiol. 1982; 33(3)347–352, [PUBMED], [INFOTRIEVE]
- Stewart J., Hoff S., Johnson D., Murray M. J., Butler D. R., Elkins C. C., Sharp K. W., Merrill W. H., Sawyers J. L. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann. Surg. 1993; 218(4)571–576, [PUBMED], [INFOTRIEVE]
- Vogel S., Mendenhall W., Sombeck M., Marsh R., Woodward E. R. Downstaging esophageal cancer after preoperative radiation and chemotherapy. Ann. Surg. 1995; 221(6)685–695, [PUBMED], [INFOTRIEVE]
- Nakayama K., Kinoshita Y. Surgical treatment combined with preoperative concentrated radiation. JAMA 1974; 227: 178–181, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Launois B., Delarue D., Campion J., Kerbaol M. Preoperative radiotherapy for carcinoma of the esophagus. Surg. Gynecol. Obstet. 1981; 153(5)690–692, [PUBMED], [INFOTRIEVE]
- Arnott S., Duncan W., Kerr G., Walbaum P. R., Cameron E., Jack W. J., Mackillop W. J. Low dose preoperative radiotherapy for carcinoma of the esophagus: results of a randomized clinical trial. Radiother. Oncol. 1992; 24(2)108–113, [PUBMED], [INFOTRIEVE]
- Gignoux M., Roussel A., Paillot B., Gillet M., Schlag P., Dalesio O., Buyse M., Duez N. The value of preoperative radiotherapy in esophageal cancer: results of the study of the EORTC. World J. Surg. 1987; 110: 426–432
- Nygaard K., Hagen S., Hansen H. S., Hatlevoll R., Hultborn R., Jakobsen A., Mantyla M., Modig H., Munck-Wikland E., Rosengren B. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J. Surg. 1992; 16(6)1104–1110, [PUBMED], [INFOTRIEVE]
- Wang M., Gu X., Yin W., Huang G. J., Wang L. J., Zhang D. W. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16(2)325–327, [PUBMED], [INFOTRIEVE]
- Arnott S. J., Duncan W., Gignoux M., Girling D. J., Hansen H. S., Launois B., Nygaard K., Parmar M. K., Roussel A., Spiliopoulos G., Stewart L. A., Tierney J. F., Mei W., Rugang Z. Preoperative radiotherapy in esophageal carcinoma: a meta analysis using individual patient data (oesophageal cancer collaborative group). Int. J. Radiat. Oncol. Biol. Phys. 1998; 41(3)579–583, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Fok M., Sham J., Choy D., Cheng S. W., Wong J. Postoprerative radiotherapy for cancer of the esophagus: a prospective, randomized controlled study. Surgery 1993; 113(2)138–147, [PUBMED], [INFOTRIEVE]
- Zieren H., Muller J., Jacobi C., Pichlmaier H., Muller R. P., Staar S. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus. World J. Surg. 1995; 19(3)444–449, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Teniere P., Hay J., Fingerhut A., Fagniez P. L. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French university association for surgical research. Surg. Gynecol. Obstet. 1991; 173(2)123–130, [PUBMED], [INFOTRIEVE]
- Kelsen D., Ginsberg R., Pajak T., Sheahan D. G., Gunderson L., Mortimer J., Estes N., Haller D. G., Ajani J., Kocha W., Minsky B. D., Roth J. A. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med. 1998; 339(27)1979–1984, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roth J., Pass H., Flanagan M., Graeber G. M., Rosenberg J. C., Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J. Thorac. Cardiovasc. Surg. 1988; 96(2)242–248, [PUBMED], [INFOTRIEVE]
- Law S., Fok M., Chow S., Chu K. M., Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J. Thorac. Cardiovasc. Surg. 1997; 114(2)210–217, [PUBMED], [INFOTRIEVE]
- Schlag P. Randomized study of preoperative chemotherapy in squamous cell cancer of the esophagus. CAO esophageal cancer study group. Chirurg 1992; 63: 709–714, [PUBMED], [INFOTRIEVE]
- Maipang T., Vasinanukorn P., Petpichetchian C., Chamroonkul S., Geater A., Chansawwaang S., Kuapanich R., Panjapiyakul C., Watanaarepornchai S., Punperk S. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J. Surg. Oncol. 1994; 56(3)191–197, [PUBMED], [INFOTRIEVE]
- Kok T., Lanscho J., Siersema P. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 1997; 16: 894, (abstract)
- Clark P. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: an updated analysis of a randomized controlled trial conducted by the UK Medical Research Council Upper al Tract Cancer Group. Proc. Am. Soc. Clin. Oncol. 2001; 20: 126, (abstract)
- Ando N., Iizuka T., Kakegawa T., Isono K., Watanabe H., Ide H., Tanaka O., Shinoda M., Takiyama W., Arimori M., Ishida K., Tsugane S. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan clinical oncology group study. J. Thorac. Cardiovasc. Surg. 1997; 114(2)205–209, [PUBMED], [INFOTRIEVE]
- Pouliquen X., Levard H., Hay J., McGee K., Fingerhut A., Langlois-Zantin O. 5-Fluorouricil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus: a multicenter randomized trial. French associations for surgical research. Ann. Surg. 1996; 223(2)127–133, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Franklin R., Steiger Z., Vaishampayan G., Asfaw I., Rosenberg J., Loh J., Hoschner J., Miller P. Combined modality therapy for esophageal squamous cell carcinoma. Cancer 1983; 51(6)1062–1071, [PUBMED], [INFOTRIEVE]
- Wong R., Malthaner R. Esophageal cancer: a systematic review. Curr. Probl. Cancer 2000; 24: 298–367
- Bhansali M., Vaidya J., Bhatt R., Patil P. K., Badwe R. A., Desai P. B. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analysis of randomized and of historical control studies. Ann. Oncol. 1996; 7(4)355–359, [PUBMED], [INFOTRIEVE]
- Bosset J., Gignoux M., Triboulet J., Tiret E., Mantion G., Elias D., Lozach P., Ollier J. C., Pavy J. J., Mercier M., Sahmoud T. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med. 1997; 337(3)161–167, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Walsh T., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T. P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med. 1996; 337(7)161–167, [CSA]
- Urba S., Orringer M., Turrisi A., Iannettoni M., Forastiere A., Strawderman M. A randomized trial comparing transhiatal esophagectomy (THE) to preoperative concurrent chemoradiation (CT/XRT) followed by esophagectomy in locoregional esophageal carcinoma (CA). J. Clin. Oncol. 2001; 19(2)283–285
- Le Prise E., Etienne P., Meunier B., Maddern G., Ben Hassel M., Gedouin D., Boutin D., Campion J. P., Launois B. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery alone for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73(7)1779–1784, [PUBMED], [INFOTRIEVE]
- Bellon J. R., Lindsley K. L., Ellis G. K., Gralow J. R., Livingston R. B., Austin M. M. Seymour, Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48(2)393–397, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koukourakis M. I., Giatromanolaki A., Schiza S., Kakolyris S., Georgoulias V. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. Int. J. Radiat. Oncol. Biol. Phys. 1999; 43(1)107–114, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tachibana M., Shibakita M., Ohno S., Kinugasa S., Yoshimura H., Ueda S., Fujii T., Rahman M. A., Dhar D. K., Nagasue N. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 2002; 94(7)1955–1960, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shimada H., Takeda A., Shiratori T., Nabeya Y., Okazumi S., Matsubara H., Funami Y., Hayashi H., Gunji Y., Kobayashi S., Suzuki T., Ochiai T. Prognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinoma. Cancer 2002; 94(7)1947–1954, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kato H., Miyazaki T., Yoshikawa M., Nakajima M., Fukai Y., Masuda N., Ojima H., Tsukada K., Nishida Y., Kuwano H. Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma. Anticancer Res. 2001; 21(5)3323–3329, [PUBMED], [INFOTRIEVE], [CSA]
- Aloia T. A., Harpole D. H., Jr., Reed C. E., Allegra C., Moore M. B., Herndon J. E., II, D'Amico T. A. Tumor marker expression is predictive of survival in patients with esophageal cancer. Ann. Thorac. Surg. 2001; 72(3)859–866, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Apinop C., Puttisak P., Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391–393, [PUBMED], [INFOTRIEVE], [CSA]